India to Poland: Irinotecan Export Trade Route

The India to Poland Irinotecan corridor is one of India's established pharmaceutical export routes, with 157 shipments documented worth a combined $4.4M USD. The route is dominated by INTAS PHARMACEUTICALS LIMITED, which alone accounts for roughly 55% of all export value, reflecting the consolidated nature of India's irinotecan manufacturing sector.

Across 4 active suppliers, the average shipment value stands at $27.9K USD — a figure that reflects both bulk commercial orders from large pharmaceutical companies and smaller specialty shipments. Freight is split between sea (67%) and air (16%), suggesting a mix of scheduled bulk orders and time-sensitive consignments.

Shipment activity peaks during January–March, with an average transit time of 17 days port-to-port. The route has recorded an annual growth rate of 10.6%, placing it at rank #20 among India's top irinotecan export destinations globally.

On the import side, key buyers of Indian irinotecan in Poland include ACCORD HEALTHCARE POLSKA SP. Z.O.O. , ACCORD HEALTHCARE POLSKA SP. Z O.O., ACCORD HEALTHCARE POLSKA SP Z O O and 11 others. ACCORD HEALTHCARE POLSKA SP. Z.O.O. is the single largest importer with 39 shipments valued at $1.0M USD.

India's irinotecan exports to Poland are driven primarily by a handful of large-scale manufacturers. INTAS PHARMACEUTICALS LIMITED with 100 shipments leads the pack, a pattern common in generic pharmaceutical corridors where manufacturing scale creates significant cost advantages. The presence of 4 active exporters signals a competitive but concentrated market — buyers in Poland benefit from supplier diversity while the top tier handles the majority of volume.

The top 3 suppliers — INTAS PHARMACEUTICALS LIMITED, INTAS PHARMACEUTICALS LIMITED , AUROBINDO PHARMA LTD — together account for 99% of total trade value on this route. The average shipment value of $27.9K USD reflects a mix of bulk commercial orders and smaller specialty shipments.

Beyond the primary product category, shipments on this route include closely related formulations such as irinotecan hydrochloride injection usp,300 mg/15 ml (irnizet 300 - ukraine) (qty: 21537 pak) and pharma drug&med: irinotecan inj,20mg/ml, , suggesting that buyers in Poland tend to consolidate orders across related product lines from the same Indian supplier.

On the buying side, ACCORD HEALTHCARE POLSKA SP. Z.O.O. is the largest importer with 39 shipments worth $1.0M USD — representing 24% of all irinotecan imports from India on this route. A total of 14 buyers are active on this corridor.